Recent news on Escitalopram Oxalate

Forest Laboratories, Inc. and Cypress Bioscience, Inc. Announce ...  -  May 23, 2007
PharmaLive.com (press release),Forest Laboratories' growing product line includes Lexapro(R) (escitalopram oxalate), an SSRI indicated for adults for the initial and maintenance treatment

Data Presented at ASH Demonstrate Nebivolol Lowers Blood Pressure ...  -  May 21, 2007
PR-Inside.com (Pressemitteilung),Forest Laboratories' growing product line includes Lexapro(R) (escitalopram oxalate), an SSRI indicated for adults for the initial and maintenance treatment

BENICAR HCT(R) Reductions in Seated Systolic Blood Pressure for ...  -  May 21, 2007
PR Newswire (press release),About Forest Laboratories and Its Products Forest Laboratories' growing line of products includes: Lexapro(R) (escitalopram oxalate), an SSRI antidepressant

Forest Laboratories, Inc. Reports Fiscal Year 2007 Fourth Quarter ...  -  Apr 24, 2007
PR-Inside.com (Pressemitteilung),Sales of Lexapro(R) (escitalopram oxalate), an SSRI indicated for the initial and maintenance treatment of major depressive disorder and generalized anxiety

Forest Laboratories, Inc. Sets Date and Conference Call for Fiscal ...  -  Apr 12, 2007
Drug Newswire (press release),Forest Laboratories' growing product line includes Lexapro(R) (escitalopram oxalate), an SSRI indicated for adults for the initial and maintenance treatment

Eli Lilly sues Sun Pharma over patent  -  Apr 1, 2007
Business Standard,...demanding to allow launch of its generic version of anxiety and depression drug Lexapro, known generically as escitalopram oxalate.

Merck & Co and Lundbeck's sleep drug terminated in Phase III  -  Mar 29, 2007
Pharma Times (subscription),...which many hoped would reduce the firm's reliance on the antidepressant Cipralex/Lexapro (escitalopram oxalate), which accounted for almost two-thirds

Lundbeck profits down but Cipralex sales continue to soar  -  Mar 8, 2007
Pharma Times (subscription),The income shortfall is the result of declining sales of the active pharmaceutical ingredient for Lexapro (escitalopram oxalate) to US licensee Forest

Second-Trimester Prenatal Diagnosis of Total Arhinia  -  Feb 26, 2007
Journal of Ultrasound in Medicine (subscription)Her medical history was notable for depression treated with escitalopram oxalate (Lexapro; Forest laboratories, St Louis, MO) at 20 mg daily.

Consumer Alert for Internet Drugs  -  Feb 22, 2007
Facts and Comparisons,Orders placed on the Internet for Ambien (zolpidem tartrate), Xanax (alprazolam), Lexapro (escitalopram oxalate), and Ativan (lorazepam) contained

Unsafe, Misrepresented Drugs Purchased Over the Internet: Ambien ...  -  Feb 19, 2007
DG NewsBETHESDA, MD -- February 19, 2007 -- FDA informed consumers and healthcare professionals regarding the possible dangers of buying prescription medications

Sepracor Announces Fourth Quarter and Full Year 2006 Results  -  Jan 31, 2007
Business Wire (press release),Patients with insomnia and GAD were randomized to receive nightly LEXAPRO ® brand escitalopram oxalate 10 mg, which is approved for the treatment of GAD,

Forest Laboratories Announces Rule 144 Sale by Executive Officer  -  Feb 15, 2007
Drug Newswire (press release),Forest Laboratories' growing product line includes Lexapro(R) (escitalopram oxalate), an SSRI indicated for adults for the initial and maintenance treatment

Forest Laboratories, Inc. Reports Q3'07 Diluted Earnings Per Share ...  -  Jan 16, 2007
Drug Newswire (press release),Sales in the quarter included $554964000 for Forest's antidepressant franchise which was comprised of $545855000 of Lexapro(R) (escitalopram oxalate),

Forest Laboratories Announces Completion of Acquisition of Cerexa ...  -  Jan 12, 2007
PharmaLive.com (press release),Forest Laboratories' growing product line includes Lexapro(R) (escitalopram oxalate), an SSRI indicated for adults for the internal and maintenance

Affective Disorder and Personality Change in a Patient With ...  -  Jan 5, 2007
Psychosomatics (subscription)Adjustment of valproate and the addition of escitalopram oxalate did not help these symptoms. However, he has benefited from regular cognitive-behavioral

Lexapro(R) Demonstrated Significance On Prospectively Defined ...  -  Dec 7, 2006
Medical News Today (press release),Lexapro is contraindicated in patients taking monoamine oxidase inhibitors (MAOIs), pimozide, or in patients with a hypersensitivity to escitalopram oxalate

Data Show Sepracor's Eszopiclone Improved Insomnia in Patients ...  -  Dec 5, 2006
DG NewsIn this study, patients who met DSM-IV®(1) criteria for both insomnia and GAD were randomized to receive nightly Lexapro® brand escitalopram oxalate 10 mg,

Data Show Sepracor's Lunesta ® Improved Insomnia in Patients with ...  -  Dec 5, 2006
Business Wire (press release),In this study, patients who met DSM-IV ®1 criteria for both insomnia and GAD were randomized to receive nightly LEXAPRO ® brand escitalopram oxalate 10 mg,

Forest Laboratories Announces Acquisition of Cerexa, Inc.  -  Dec 15, 2006
PipelineReview.com (press release),Forest Laboratories' growing product line includes Lexapro(R) (escitalopram oxalate), an SSRI indicated for adults for the internal and maintenance

Lundbeck says Lexapro depression treatment better tolerated than ...  -  Dec 6, 2006
Forbes,...depression treatment, Lexapro/Cipralex (escitalopram oxalate), against Cymbalta (duloxetine), a depression treatment made by Eli Lilly and Co.

Lexapro®/Cipralex® demonstrated significance on prospectively ...  -  Dec 6, 2006
WebWire (press release),Inc. today announced the results of a new head to head study of Lexapro®/Cipralex® (escitalopram oxalate) versus Cymbalta® (duloxetine).

Forest Laboratories (FRX) Announces New Study Results for Lexapro  -  Dec 6, 2006
StreetInsider.com (subscription),Forest Laboratories, Inc., (NYSE: FRX) announced the results of a new study demonstrating that Lexapro (escitalopram oxalate) provided a greater reduction

Forest Laboratories Reports Earnings Per Share of $0.75 for Q2'07  Oct 17, 2006
Sales in the quarter included $522,662,000 for Lexapro(R) (escitalopram oxalate), our SSRI for the treatment of depression and anxiety in adults, an increase ... -MSN Money Patient Recruitment For Desmoteplase Phase IIB/III Stroke Study ...  Oct 26, 2006
Forest Laboratories' growing product line includes Lexapro(R) (escitalopram oxalate), an SSRI indicated for adults for the initial and maintenance treatment of ... -Medical News Today (press release), Forest Laboratories Inc. Announces Appointment of Dr. Lawrence S. ...  Sep 7, 2006
Forest Laboratories' growing product line includes Lexapro(R) (escitalopram oxalate), an SSRI indicated for adults for the initial and maintenance treatment of ... -PR Newswire

Lexapro(R) Demonstrated Significance On Prospectively Defined ...  -  Dec 7, 2006
Medical News Today (press release),Lexapro is contraindicated in patients taking monoamine oxidase inhibitors (MAOIs), pimozide, or in patients with a hypersensitivity to escitalopram oxalate

Data Show Sepracor's Eszopiclone Improved Insomnia in Patients ...  -  Dec 5, 2006
DG NewsIn this study, patients who met DSM-IV®(1) criteria for both insomnia and GAD were randomized to receive nightly Lexapro® brand escitalopram oxalate 10 mg,

Data Show Sepracor's Lunesta ® Improved Insomnia in Patients with ...  -  Dec 5, 2006
Business Wire (press release),In this study, patients who met DSM-IV ®1 criteria for both insomnia and GAD were randomized to receive nightly LEXAPRO ® brand escitalopram oxalate 10 mg,

Lundbeck says Lexapro depression treatment better tolerated than ...  -  Dec 6, 2006
Forbes,...depression treatment, Lexapro/Cipralex (escitalopram oxalate), against Cymbalta (duloxetine), a depression treatment made by Eli Lilly and Co.

Lexapro®/Cipralex® demonstrated significance on prospectively ...  -  Dec 6, 2006
WebWire (press release),Inc. today announced the results of a new head to head study of Lexapro®/Cipralex® (escitalopram oxalate) versus Cymbalta® (duloxetine).

Forest Laboratories (FRX) Announces New Study Results for Lexapro  -  Dec 6, 2006
StreetInsider.com (subscription),Forest Laboratories, Inc., (NYSE: FRX) announced the results of a new study demonstrating that Lexapro (escitalopram oxalate) provided a greater reduction

Lundbeck shares slip as profits slide  Aug 16, 2006
...in profit had been expected after Lundbeck warned of declining sales of the active pharmaceutical ingredient (API) for Lexapro (escitalopram oxalate) to US ... -Pharma Times (subscription)

Forest Laboratories, Inc. Reports Fiscal First Quarter 2007 ...  Jul 18, 2006
Sales in the quarter included $507,033,000 for Lexapro(R) (escitalopram oxalate), our SSRI for the treatment of depression and anxiety in adults, an increase ... -MSN Money

Forest Laboratories Q1 Profit Declines 7% On Charges; Raises FY07 ...  Jul 18, 2006
...sales rose 12% to $758.77 million from $674.65 million in last-year quarter, and included $507.03 million from sales of Lexapro or escitalopram oxalate, a drug ... -Trading Markets

Forest Announces Federal Court Upholds Lexapro(R) Patent  Jul 13, 2006
Forest Laboratories' growing product line includes Lexapro(R) (escitalopram oxalate), an SSRI indicated for adults for the initial and maintenance treatment of ... -International News Service

Court backs Forest in Lexapro patent dispute  Jul 14, 2006
Teva Pharmaceutical Industries failed in a bid to overturn the patent protection for Lexapro (escitalopram oxalate), the last barrier to launching its generic ... -Pharma Times (subscription)

H. Lundbeck A/S and Forest Laboratories, Inc. file lawsuit against ...  Jul 11, 2006
Forest Laboratories’ growing line of products includes: Lexapro® (escitalopram oxalate), an SSRI antidepressant indicated for the initial and maintenance ... -WebWire



Generalized Anxiety Disorder  May 6, 2006
Now, newer ones, like Lexapro(r) (escitalopram oxalate) and EFFEXOR XR(r) (venlafaxine HCl), are helpful and have minimal side effects. ... - WOWT

Forest Laboratories, Inc. Reports Q4'06 Diluted Earnings Per Share ...  Apr 25, 2006
Sales of Lexapro® (escitalopram oxalate), an SSRI indicated for the initial and maintenance treatment of major depressive disorder and generalized anxiety ... - Yahoo! News

Forest Laboratories Signs Grants Manager Agreement With Fast Track ...  Apr 19, 2006
Forest Laboratories' growing line of products includes: Lexapro ® (escitalopram oxalate), an SSRI antidepressant indicated for the initial and maintenance ... - Market Wire

Forest Laboratories Fiscal 2007 Guidance  Apr 26, 2006
Forest Laboratories' growing product line includes Lexapro(R) (escitalopram oxalate), an SSRI indicated for adults for the initial and maintenance treatment of ... - Webbolt Business News





Forest and Almirall Announce a Development and Marketing ...  Apr 10, 2006
Forest Laboratories' growing product line includes Lexapro(R) (escitalopram oxalate), an SSRI indicated for adults for the initial and maintenance treatment of ... - Finanzen.net

Forest Laboratories Receives Patent Term Extension for Lexapro  Mar 2, 2006
34,712. The patent covers the composition of matter for Lexapro(R) (escitalopram oxalate) an SSRI approved for the treatment of Major Depressive Disorder and ... - Finanzen.net,

Replidyne and Forest Laboratories Announce FDA Acceptance for ...  Feb 23, 2006
...and Its Products: Forest Laboratories' (http://www.frx.com) growing line of products includes: Lexapro(R) (escitalopram oxalate), a selective serotonin ... - PR Newswire,

Forest Laboratories, Inc. Reports Q3'06 Diluted Earnings Per Share ...  Jan 17, 2006
...in the quarter included $485,687,000 for Forest's antidepressant franchise which was comprised of $480,707,000 of Lexapro(R) (escitalopram oxalate), an SSRI ... - MSN Money

Mylan Laboratories and Forest Laboratories Announce Nebivolol ...  Jan 12, 2006
...and Its Products Forest Laboratories' (www.frx.com) growing line of products includes: Lexapro(R) (escitalopram oxalate), an SSRI antidepressant indicated for ... - PharmaLive.com

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional